A “cancer-killing pill” has appeared to “annihilate” solid tumours in early research – leaving healthy cells unaffected.
The new drug has been in development for 20 years, and is now undergoing pre-clinical research in the US.
Researchers at City of Hope, one of the US’ largest cancer research and treatment organisations, published a study on Tuesday detailing early test results of “cancer-killing pill” AOH1996.
While the drug’s name may appear to be a random mix of numbers and letters, it actually symbolises a little girl who lost her life to a rare cancer.
Anna Olivia Healey was born in 1996 and died just 10-years-later from Neuroblastoma.
Since her death her family have been donating money to Linda Malkas, who has spent 20 years developing AOH1996 at the City of Hope hospital in California.
The charity, A.N.N.A. Fund has raised $400,000 (£312,000) for neuroblastoma research and families impacted by the disease.
AOH1996 targets a cancerous variant of proliferating cell nuclear antigen (PCNA) – this is a protein that plays a critical role in making tumours expand, the City of Hope said.
Professor Malkas, works at the Californian treatment centre’s department of molecular diagnostics and experimental therapeutics.
Read More ( Here )
© CopyRights RawNews1st
